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BACKGROUND: Measurement of cholesterol and triglyceride (TG) fractions in blood has become standard practice in the early
detection of atherosclerotic disease pathways. Considerable attention is given nowadays to the presence of these risk factors in
children and to start preventive campaigns early in life. In this context, it is imperative to have valid comparative frameworks for
interpretation of lipid levels. The aim of this study is to present sex- and age-speciﬁc reference values on blood lipid levels in
European children aged 2.0–10.9 years.
METHODS: Fasting blood was obtained via either venipuncture or capillary sampling. In 13 579 European non-obese children
(50.3% boys), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), TG and
TC/HDL-C ratio levels were measured with a point-of-care analyser (Cholestech). Sex- and age-speciﬁc reference values were
computed with the GAMLSS method with the statistical software R.
RESULTS: Reference curves and 1st, 3rd, 10th, 25th, 50th, 75th, 90th, 97th and 99th percentile values are presented. HDL-C showed
a positive trend with age, from 2 years onwards, but was relatively stable above the age of 7. For LDL-C and TC, linear but small
age-related trends were seen. The TC/HDL-C values showed a gradual negative trend from the age of 2 up to 6 and were relatively
stable afterwards. For TG, no age trend was found (P= 0.285). Boys had higher mean HDL-C values than girls (1.414 vs
1.368mmol l− 1), and lower TC, LDL-C, TC/HDL-C and TG values (3.981 vs 4.087 mmol l− 1; 2.297 vs 2.435 mmol l− 1; 2.84 vs
3.01mmol l− 1; and 0.509 vs 0.542mmol l− 1, respectively).
CONCLUSIONS: These new and recent references could serve as a European orientation of blood lipid values in children in the
context of standard medical practice and for the purpose of public health screening.
International Journal of Obesity (2014) 38, S67–S75; doi:10.1038/ijo.2014.137
INTRODUCTION
In the biomedical literature, the term ‘blood lipids’ most
commonly refers to the circulating fractions of cholesterol and
triglycerides (TG), biomolecules that are insoluble in water and are
therefore embedded in larger structures with a water soluble
protein backbone—these structures in the plasma are called
lipoproteins. Lipoproteins are further classiﬁed in several sub-
categories, mainly on the basis of their composition and density.1
The main lipid subcategories are very-low-density lipoproteins,
low-density lipoproteins (LDL), intermediate-density lipoproteins
and high-density lipoproteins (HDL). Triglycerides are structural
part of all lipoproteins and are often treated as a separate
category in the context of medical laboratory research.
Lipoprotein and triglyceride concentrations in blood are a
reﬂection of the fat metabolism in the human body and are
known to be modulated by genetic background and environ-
mental determinants—like diet, physical activity, alcohol use,
smoking and so on. Measurement of these lipid fractions in blood
has become standard medical and public health practice for early
detection of disease pathways involving hereditary- and/or
lifestyle-induced disturbances of lipid metabolism. Their role in
the typical vascular damage leading to atherosclerotic diseases is
now fairly well documented2–4 and also non-atherosclerotic
diseases have been related to blood and tissue lipids, like some
neurodegenerative diseases and rheumatoid arthritis.5–7 Special
attention for these lipids is now integrated in a broad context of
primary disease prevention and promotion of healthy lifestyle.8,9
Indeed, serum lipids have been in the overall picture of the diet-
disease paradigm now since more than half a century already. The
ﬁrst reports on the relation between diet, blood lipids and
cardiovascular diseases (the initial famous so-called ‘diet-heart
hypothesis’) were from the Seven Countries Study.10,11
Blood lipids have gone through a remarkable journey of
rescaling and resetting the optimal plasma range for deﬁning their
relevance as risk factors. A complementary set of comparative
population studies, long-term follow-up studies, clinical studies
and in vitro experiments have led to a gradual decrease in what is
considered an optimal range of serum lipid levels for disease
prevention. Population targets for total cholesterol (TC) and LDL
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cholesterol (LDL-C) are today set at 4.9 and 3mmol l− 1,
respectively.9,12,13
Meanwhile, it became increasingly obvious that this lifestyle–
disease association was already operational in the early stages of
life and that risk factors established during childhood have a
tendency to track into adulthood and to add to the overall risk
proﬁle for chronic diseases.14–16 Considerable attention is there-
fore given nowadays to the presence of risk factors in children and
to start addressing them in preventive campaigns.17
Against this background, it is of course imperative to have valid
comparative frameworks for the interpretation of individual values
and population distributions of risk markers like blood lipids.
Therefore, the aim of this study is to present sex- and age-speciﬁc
reference values on blood lipid levels (HDL cholesterol (HDL-C),
LDL-C, TC, triglycerides (TG), TC/HDL-C) in European children aged
2.0–10.9 years.
SUBJECTS AND METHODS
Study subjects
A cohort of 16 228 children aged 2–9 years was examined in a population-
based baseline survey in eight countries geographically distributed across
Europe from North to South and from East to West (Sweden, Germany,
Hungary, Italy, Cyprus, Spain, Belgium and Estonia). Standardised instru-
ments and protocols were used for a large battery of measurements done
in a period between autumn 2007 and spring 2008.18
The study was not designed to provide a representative sample for each
country. Rather, the baseline survey (T0) was the starting point for a
longitudinal scientiﬁc project based on the largest European children’s
cohort established to date.18 This cohort and an additional 2517 children
aged 2.0–10.9 years who were newly recruited during a second (ﬁrst
follow-up) survey (T1) 2 years later constitute the actual study population
for the present analysis. Exactly the same survey modules were deployed
at baseline (T0) and at follow-up (T1).
All children in the deﬁned age group who resided in the selected
regions and who attended the primary schools (grades 1 and 2), pre-
schools or kindergartens were eligible for participation. Children were
approached via schools and kindergartens to facilitate uniform enrolment
across all social classes. In addition to the signed informed consent given
by parents, each child was asked to give verbal assent immediately before
examination. Participants were free to volunteer or renounce for speciﬁc
modules like, for instance, the blood drawing.
Children who were ill at the time of visit were excluded for blood
withdrawal. Valid blood lipid data were eventually available for 14 673
children. Of these children, 1094 obese children were excluded from the
analyses to reﬂect as much as possible the biological variation in a disease-
free population, resulting in a ﬁnal study population of 13 579 children for
establishing the reference value database. Outliers have not been
excluded. The ﬂow chart in Figure 1 summarises the exclusion steps. The
analysis group did not differ in sex distribution from the excluded sample,
but the included children were older (6.4 vs 5.9 years, Po0.001).
Body mass index
The children were measured barefooted in underwear and/or T-shirt.
Weight was measured in fasting status with an electronic scale (TANITA BC
420 SMA, Tanita Europe GmbH, Sindelﬁngen, Germany) to the nearest
0.1 kg. Height was measured with a telescopic height measuring
instrument (seca 225, stadiometer, seca, Birmingham, UK) to the nearest
0.1 cm. The BMI (body mass index) was obtained as follows:
BMI =weight (kg)/height (m)2. Children were classiﬁed as obese according
to the new International Obesity Task Force criteria using BMI centiles
(98.9th centile for obesity in boys, 98.6th centile for obesity in girls).19
Blood collection
Fasting blood was obtained from all children via either venipuncture
(65.1% of the children) or capillary sampling (34.9%). It was anticipated that
a sizeable number of children would refuse the venipuncture even with
local anaesthesia, for example, lidocaïne-prilocaïne (EMLA, AstraZeneca,
London, UK) patches provided. Signiﬁcantly higher levels of TC, HDL-C and
LDL-C and signiﬁcantly lower levels of TG were found in the venous
samples vs the capillary samples (all Po0.001).
To ensure that at least basic data on metabolic risk markers were
available for as many children as possible, a so-called ‘point-of-care
analyser’ was used for both the capillary and the venous blood samples.
This technique—Cholestech LDX (Cholestech, Hayward, CA, USA)—
allowed to assess on the spot values for blood glucose, HDL-C and TC
and TG using one drop of either capillary blood from the ﬁngertip or taken
from the serum tube (http://www.cholestech.com/products/ldx_overview.
htm). This portable device has been validated for lipid analyses against
standard laboratory methods in adults (r between 0.91 and 0.99; no
signiﬁcant mean bias)20 and the system is certiﬁed by the Centers
for Disease Control cholesterol reference method laboratory network.
The detection ranges are: TC range 2.6–12.9 mmol l− 1; TG range
0.50–7.31mmol l− 1; and HDL-C range 0.39–2.62mmol l− 1. LDL-C was not
measured directly through this technique, but calculated using the
Friedewald formula LDL-C = TC−HDL-C− TG/5.0 (mg dl− 1) based on the
Cholestech results.21
Quality management
All measurements followed detailed standard operating procedures that
were laid down in the general survey manual and were ﬁnalised after the
pre-test of all survey modules. Field personnel from each study centre
participated in central training and organised local training sessions
thereafter. The coordinating centre conducted site visits to each study
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Figure 1. Flow chart explaining the sample size reduction.
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location during ﬁeld surveys to check adherence of ﬁeld staff to the
standard operating procedures. All study centres used the same technical
equipment that was purchased centrally to maximise comparability of
data. Databases and computer-assisted questionnaires included auto-
mated plausibility checks. All numerical variables were entered twice
independently. Inconsistencies identiﬁed by additional plausibility checks
were rectiﬁed by the study centres. To further check for the quality of data,
sub-samples of study subjects were examined repeatedly to calculate the
inter- and intra-observer reliability of anthropometric measurements.22,23
Statistical analysis
We calculated percentile curves of blood lipids (HDL-C, LDL-C, TC, TG,
TC/HDL-C) as a function of the covariate age stratiﬁed by sex using the
General Additive Model for Location Scale and Shape (GAMLSS) as
extension of the least mean squares method. The least mean squares
method models three parameters: the skewness (L) accounts for the
deviation from a normal distribution using a Box–Cox transformation
(Box–Cox t), the median (M) models the outcome variable depending on
one explanatory variable and the coefﬁcient of variation (S) accounts for
the variation of data points around the mean and adjusts for non-uniform
dispersion. The GAMLSS is able to model more than one covariate and also
other distributions. We used the GAMLSS package (version 4.2–6) of the
statistical software R (version 3.0.1, www.cran.r-project.org).24 Different
distributions, that is, the logistic, normal, inverse Gaussian, Box–Cox t,
Box–Cox power exponential and Box–Cox Cole and Green, were ﬁtted to
the observed distribution of blood lipids. Moreover, the inﬂuence of age on
parameters of the considered distributions was modelled either as a
constant, as a linear function, or as a cubic spline of the covariate.
Goodness of ﬁt was assessed by the Bayesian Information Criterion and
Q-Q plots to select the ﬁnal model including the ﬁtted distribution of blood
lipids and the inﬂuence of covariates on distribution parameters. Worm
plots were used as a diagnostic tool to assess whether adjustment for
kurtosis was required.25 Finally, percentile curves for the 1st, 3rd, 10th,
25th, 50th, 75th, 90th, 97th and 99th percentiles were calculated based on
the model that showed the best goodness of ﬁt.24,26 Sensitivity analyses
were executed to assess the effect of excluding obese children and
capillary blood samples.
RESULTS
Table 1 describes the analysis group of 13 579 non-obese
European children, 50.3% boys.
Signiﬁcant sex differences were found for all blood lipid
variables (Po0.001): HDL-C values were higher in boys and TC,
LDL-C, TC/HDL-C and TG were higher in girls. Signiﬁcant
correlations with age were found for all cholesterol values
(Po0.001): an age-related positive trend for TC and HDL-C but
an age-related negative trend for LDL-C and TC/HDL-C. For TG, no
signiﬁcant correlation with age was detected (P= 0.285). Conse-
quently, age non-speciﬁc reference values are given for TG. In this
context, it should be noted that the TG levels were often below
the detection limit of 0.50 mmol l− 1.
Apart from age and sex, also seasonal differences were
detected. The school visits were executed from the end of
September until the beginning of June with a uniform distribution
over the months. Analysis of variance analyses showed no
difference in TC between the months during the survey period,
but HDL-C was highest in April and LDL-C and triglycerides were
highest in October, November and December.
The best ﬁt in GAMLSS was retrieved for HDL-C using the
Box–Cox power exponential distribution with parameters mod-
elled in both sexes as follows: μ as a cubic spline, log(σ) linearly
and the shape parameters ν and log(τ) as constants. For LDL, the
best ﬁt was obtained using the Box–Cox t distribution with
parameters modelled as follows: μ linearly and log(σ), ν and log(τ)
as constants. For TC, using the inverse Gaussian distribution
with parameters log(μ) and log(σ) modelled linearly. Finally, for
TC/HDL-C, using the Box–Cox t distribution with parameters
modelled as follows: μ as a cubic spline, log(σ) linearly and ν and
log(τ) as constants.
The reference values for blood lipids are shown in Table 2 for
boys and Table 3 for girls. Percentile curves are presented in
Figure 2. HDL-C showed a positive age trend up to the age of
7 and was relatively stable afterwards. For LDL-C and TC, linear
but small age-related changes were seen. The TC/HDL-C values
showed a gradual decrease from the age of 2 up to 6 and were
relatively stable afterwards. Sensitivity analyses revealed that
the percentile values did not really differ when excluding
obese children or when excluding capillary blood samples
(Supplementary Figures A and B). In Supplementary Table A of
the Supplementary Material, reference values are given for the
whole sample without exclusion for obesity.
DISCUSSION
It has been shown convincingly that atherosclerotic changes in
the vessel wall often already start during youth in populations that
have adopted a modern Western lifestyle with its typical high-fat
energy dense diet and sedentary pattern.27 In view of this
observation, early screening of blood lipid values in children and
adolescents can indeed be warranted from the point of view of
cardiovascular disease prevention.28 To do this in a scientiﬁcally
sound way, the availability of valid data on normal blood lipid
distributions is an imperative premise.
In this paper, we present age- and sex-speciﬁc reference values
for blood TG, TC, LDL-C, HDL-C and TC/HDL-C ratio from a large
sample of European children aged 2.0–10.9 years. Percentile
curves were calculated with the so-called GAMLSS, developed by
Rigby and Stasinopoulos.29 This method is an extension of the
least mean squares method to model the distribution of blood
lipids depending on age, while accounting for dispersion,
skewness and particularly the kurtosis of this distribution.26,29
This GAMLSS is today generally accepted as standard technique
for establishing reference curves for biological parameters. At the
Table 1. Descriptive data of the analysis group (n= 13 579)
Boys (N=6828) Girls (N= 6751)
N % N %
Age
2.0–2.9 222 3.3 196 2.9
3.0–3.9 809 11.8 758 11.2
4.0–4.9 973 14.3 885 13.1
5.0–5.9 842 12.3 766 11.3
6.0–6.9 1080 15.8 1128 16.7
7.0–7.9 1457 21.3 1522 22.5
8.0–8.9 981 14.4 1003 14.9
9.0–9.9 316 4.6 349 5.2
10.0–10.9 148 2.2 144 2.1
Weight statusa
Underweight 795 11.6 787 11.7
Normal 5105 74.8 4890 72.4
Overweight 928 13.6 1074 15.9
Country
Italy 855 12.5 789 11.7
Estonia 834 12.2 923 13.7
Cyprus 976 14.3 948 14.0
Belgium 552 8.1 534 7.9
Sweden 813 11.9 786 11.6
Germany 847 12.4 829 12.3
Hungary 1291 18.9 1315 19.5
Spain 660 9.7 627 9.3
aAccording to the International Obesity Task Force criteria (Cole and
Lobstein19).
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Table 2. Age-speciﬁc reference values for blood lipids in boys
Percentile: 1st 3rd 10th 25th 50th 75th 90th 97th 99th
HDL-C (mmol l− 1)
2–2.5 years 0.430 0.562 0.743 0.925 1.127 1.334 1.456 1.676 1.764
2.5–3 years 0.451 0.585 0.769 0.958 1.160 1.373 1.497 1.722 1.813
3–3.5 years 0.471 0.609 0.798 0.987 1.197 1.412 1.538 1.766 1.860
3.5–4 years 0.492 0.632 0.824 1.018 1.230 1.450 1.577 1.808 1.904
4–4.5 years 0.513 0.655 0.850 1.049 1.264 1.487 1.616 1.852 1.948
4.5–5 years 0.534 0.679 0.875 1.077 1.295 1.523 1.655 1.893 1.989
5–5.5 years 0.554 0.699 0.901 1.106 1.326 1.557 1.691 1.932 2.031
5.5–6 years 0.572 0.723 0.927 1.134 1.360 1.590 1.728 1.971 2.072
6–6.5 years 0.593 0.746 0.953 1.163 1.388 1.624 1.761 2.007 2.108
6.5–7 years 0.611 0.767 0.974 1.186 1.414 1.650 1.787 2.036 2.137
7–7.5 years 0.627 0.782 0.992 1.202 1.432 1.668 1.805 2.054 2.157
7.5–8 years 0.640 0.795 1.005 1.215 1.443 1.678 1.818 2.064 2.165
8–8.5 years 0.650 0.803 1.013 1.222 1.448 1.684 1.821 2.064 2.165
8.5–9 years 0.660 0.811 1.018 1.225 1.450 1.684 1.818 2.062 2.160
9–9.5 years 0.668 0.818 1.023 1.230 1.453 1.684 1.816 2.056 2.155
9.5–10 years 0.679 0.829 1.031 1.235 1.456 1.686 1.818 2.056 2.155
10–10.5 years 0.689 0.837 1.041 1.243 1.463 1.689 1.821 2.059 2.155
10.5–10.9 years 0.699 0.850 1.052 1.254 1.471 1.696 1.829 2.064 2.160
LDL-C (mmol l− 1)
2–2.5 years 1.010 1.272 1.629 1.999 2.432 2.916 3.206 3.776 4.033
2.5–3 years 1.002 1.264 1.619 1.987 2.416 2.898 3.186 3.753 4.007
3–3.5 years 0.997 1.256 1.608 1.974 2.404 2.880 3.168 3.730 3.983
3.5–4 years 0.992 1.248 1.598 1.961 2.388 2.862 3.147 3.706 3.958
4–4.5 years 0.984 1.241 1.590 1.950 2.372 2.844 3.129 3.683 3.932
4.5–5 years 0.979 1.233 1.580 1.937 2.357 2.826 3.108 3.660 3.908
5–5.5 years 0.971 1.225 1.570 1.924 2.341 2.808 3.087 3.636 3.882
5.5–6 years 0.966 1.217 1.559 1.911 2.328 2.789 3.069 3.613 3.859
6–6.5 years 0.961 1.210 1.549 1.901 2.313 2.771 3.048 3.590 3.833
6.5–7 years 0.953 1.202 1.538 1.888 2.297 2.753 3.028 3.566 3.807
7–7.5 years 0.948 1.194 1.528 1.875 2.282 2.735 3.010 3.543 3.784
7.5–8 years 0.940 1.186 1.518 1.862 2.266 2.717 2.989 3.520 3.758
8–8.5 years 0.935 1.178 1.510 1.852 2.253 2.699 2.971 3.497 3.735
8.5–9 years 0.930 1.171 1.500 1.839 2.238 2.681 2.950 3.473 3.709
9–9.5 years 0.922 1.163 1.489 1.826 2.222 2.663 2.929 3.450 3.683
9.5–10 years 0.917 1.155 1.479 1.813 2.207 2.644 2.911 3.427 3.660
10–10.5 years 0.909 1.147 1.469 1.803 2.194 2.629 2.890 3.403 3.634
10.5–10.9 years 0.904 1.140 1.458 1.790 2.178 2.611 2.870 3.380 3.610
TC (mmol l− 1)
2–2.5 years 2.471 2.694 3.030 3.416 3.906 4.465 4.797 5.408 5.664
2.5–3 years 2.484 2.707 3.041 3.427 3.913 4.470 4.799 5.405 5.662
3–3.5 years 2.499 2.720 3.054 3.437 3.921 4.476 4.802 5.405 5.657
3.5–4 years 2.512 2.732 3.067 3.447 3.929 4.481 4.804 5.403 5.654
4–4.5 years 2.525 2.748 3.080 3.458 3.937 4.486 4.807 5.403 5.651
4.5–5 years 2.538 2.761 3.090 3.468 3.947 4.491 4.812 5.400 5.646
5–5.5 years 2.554 2.774 3.103 3.481 3.955 4.494 4.815 5.400 5.644
5.5–6 years 2.567 2.787 3.116 3.491 3.963 4.499 4.817 5.398 5.641
6–6.5 years 2.580 2.800 3.126 3.502 3.970 4.504 4.820 5.398 5.638
6.5–7 years 2.593 2.813 3.139 3.512 3.981 4.509 4.823 5.395 5.636
7–7.5 years 2.608 2.826 3.152 3.522 3.989 4.514 4.825 5.395 5.631
7.5–8 years 2.621 2.839 3.165 3.533 3.996 4.522 4.830 5.395 5.628
8–8.5 years 2.634 2.852 3.175 3.543 4.004 4.527 4.833 5.392 5.625
8.5–9 years 2.650 2.865 3.188 3.553 4.015 4.533 4.836 5.392 5.623
9–9.5 years 2.663 2.877 3.201 3.566 4.022 4.538 4.838 5.392 5.620
9.5–10 years 2.675 2.893 3.212 3.577 4.030 4.543 4.843 5.390 5.618
10–10.5 years 2.691 2.906 3.225 3.587 4.038 4.548 4.846 5.390 5.618
10.5–10.9 years 2.704 2.919 3.238 3.598 4.046 4.553 4.848 5.390 5.615
TC/HDL-C
2–2.5 years 1.98 2.21 2.55 2.95 3.50 4.23 4.75 5.98 6.66
2.5–3 years 1.93 2.16 2.49 2.87 3.40 4.10 4.60 5.78 6.42
3–3.5 years 1.88 2.10 2.42 2.80 3.30 3.98 4.46 5.58 6.19
3.5–4 years 1.84 2.05 2.36 2.73 3.22 3.87 4.32 5.40 5.98
4–4.5 years 1.80 2.01 2.31 2.66 3.14 3.76 4.20 5.24 5.80
4.5–5 years 1.77 1.97 2.27 2.61 3.07 3.67 4.10 5.09 5.62
5–5.5 years 1.74 1.94 2.22 2.55 3.00 3.59 4.00 4.95 5.47
5.5–6 years 1.71 1.91 2.18 2.51 2.94 3.51 3.90 4.83 5.32
6–6.5 years 1.69 1.88 2.15 2.46 2.89 3.44 3.82 4.71 5.19
6.5–7 years 1.67 1.85 2.12 2.43 2.84 3.38 3.75 4.61 5.07
7–7.5 years 1.66 1.84 2.10 2.40 2.81 3.33 3.70 4.53 4.98
7.5–8 years 1.65 1.83 2.09 2.39 2.78 3.30 3.66 4.47 4.91
8–8.5 years 1.65 1.83 2.09 2.39 2.78 3.29 3.64 4.44 4.86
8.5–9 years 1.66 1.84 2.09 2.39 2.78 3.28 3.63 4.42 4.83
9–9.5 years 1.66 1.84 2.09 2.38 2.77 3.27 3.61 4.38 4.79
9.5–10 years 1.66 1.84 2.09 2.37 2.75 3.24 3.58 4.34 4.73
10–10.5 years 1.66 1.83 2.08 2.36 2.73 3.21 3.54 4.28 4.67
10.5–10.9 years 1.65 1.82 2.07 2.35 2.71 3.18 3.51 4.23 4.61
Triglycerides (mmol l− 1)
2–10.9 years 0.509 0.509 0.509 0.509 0.509 0.687 0.949 1.446 1.970
Abbreviations: HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TC, total cholesterol.
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Table 3. Age-speciﬁc reference values for blood lipids in girls
Percentile: 1st 3rd 10th 25th 50th 75th 90th 97th 99th
HDL-C (mmol l− 1)
2–2.5 years 0.386 0.510 0.684 0.860 1.054 1.256 1.375 1.590 1.681
2.5–3 years 0.407 0.536 0.712 0.896 1.093 1.303 1.425 1.647 1.738
3–3.5 years 0.430 0.562 0.743 0.930 1.134 1.347 1.471 1.699 1.792
3.5–4 years 0.451 0.585 0.774 0.963 1.173 1.391 1.520 1.751 1.847
4–4.5 years 0.471 0.611 0.803 0.997 1.210 1.432 1.564 1.803 1.898
4.5–5 years 0.492 0.635 0.831 1.028 1.246 1.471 1.606 1.847 1.945
5–5.5 years 0.513 0.658 0.855 1.057 1.277 1.507 1.642 1.886 1.987
5.5–6 years 0.534 0.681 0.883 1.088 1.311 1.544 1.678 1.927 2.028
6–6.5 years 0.554 0.702 0.907 1.114 1.339 1.575 1.715 1.963 2.067
6.5–7 years 0.572 0.723 0.930 1.140 1.368 1.606 1.743 1.997 2.100
7–7.5 years 0.591 0.741 0.951 1.160 1.391 1.629 1.769 2.023 2.126
7.5–8 years 0.606 0.756 0.966 1.178 1.406 1.645 1.785 2.038 2.145
8–8.5 years 0.616 0.769 0.976 1.189 1.417 1.655 1.792 2.046 2.150
8.5–9 years 0.627 0.777 0.984 1.194 1.419 1.655 1.792 2.044 2.147
9–9.5 years 0.635 0.782 0.987 1.194 1.417 1.650 1.787 2.033 2.137
9.5–10 years 0.640 0.787 0.989 1.194 1.414 1.645 1.779 2.023 2.124
10–10.5 years 0.645 0.793 0.992 1.191 1.409 1.637 1.769 2.010 2.108
10.5–10.9 years 0.650 0.795 0.992 1.189 1.404 1.627 1.756 1.992 2.090
LDL-C (mmol l− 1)
2–2.5 years 1.093 1.349 1.704 2.077 2.523 3.017 3.313 3.872 4.118
2.5–3 years 1.088 1.344 1.696 2.069 2.515 3.007 3.300 3.857 4.103
3–3.5 years 1.085 1.339 1.691 2.062 2.505 2.994 3.287 3.841 4.087
3.5–4 years 1.080 1.334 1.684 2.054 2.494 2.984 3.274 3.828 4.069
4–4.5 years 1.077 1.329 1.678 2.046 2.484 2.971 3.261 3.812 4.053
4.5–5 years 1.072 1.323 1.671 2.038 2.476 2.960 3.248 3.797 4.038
5–5.5 years 1.067 1.318 1.663 2.031 2.466 2.947 3.235 3.781 4.022
5.5–6 years 1.064 1.313 1.658 2.023 2.455 2.937 3.222 3.768 4.007
6–6.5 years 1.059 1.308 1.650 2.015 2.445 2.924 3.209 3.753 3.991
6.5–7 years 1.054 1.303 1.645 2.005 2.435 2.914 3.196 3.737 3.976
7–7.5 years 1.052 1.298 1.637 1.997 2.427 2.901 3.183 3.722 3.958
7.5–8 years 1.046 1.292 1.632 1.989 2.416 2.890 3.170 3.706 3.942
8–8.5 years 1.044 1.287 1.624 1.981 2.406 2.877 3.157 3.693 3.926
8.5–9 years 1.039 1.282 1.619 1.974 2.396 2.867 3.144 3.678 3.911
9–9.5 years 1.033 1.277 1.611 1.966 2.388 2.854 3.131 3.662 3.895
9.5–10 years 1.031 1.272 1.606 1.958 2.378 2.844 3.121 3.647 3.880
10–10.5 years 1.026 1.267 1.598 1.950 2.367 2.831 3.108 3.631 3.864
10.5–10.9 years 1.020 1.261 1.590 1.943 2.357 2.818 3.095 3.618 3.846
TC (mmol l− 1)
2–2.5 years 2.484 2.712 3.054 3.450 3.950 4.525 4.867 5.496 5.760
2.5–3 years 2.502 2.730 3.072 3.465 3.965 4.538 4.877 5.504 5.765
3–3.5 years 2.523 2.748 3.090 3.484 3.981 4.551 4.887 5.509 5.771
3.5–4 years 2.541 2.766 3.108 3.499 3.996 4.561 4.898 5.514 5.773
4–4.5 years 2.559 2.787 3.126 3.517 4.012 4.574 4.908 5.522 5.778
4.5–5 years 2.577 2.805 3.144 3.533 4.025 4.587 4.918 5.527 5.783
5–5.5 years 2.598 2.823 3.162 3.551 4.040 4.600 4.929 5.535 5.789
5.5–6 years 2.616 2.844 3.181 3.569 4.056 4.610 4.939 5.540 5.791
6–6.5 years 2.637 2.862 3.199 3.585 4.071 4.623 4.949 5.548 5.796
6.5–7 years 2.655 2.880 3.217 3.603 4.087 4.636 4.960 5.556 5.802
7–7.5 years 2.673 2.901 3.238 3.621 4.103 4.649 4.970 5.561 5.807
7.5–8 years 2.694 2.919 3.256 3.636 4.118 4.662 4.983 5.569 5.812
8–8.5 years 2.712 2.937 3.274 3.654 4.134 4.675 4.994 5.576 5.817
8.5–9 years 2.732 2.958 3.292 3.673 4.149 4.688 5.004 5.581 5.822
9–9.5 years 2.751 2.976 3.310 3.688 4.165 4.701 5.014 5.589 5.830
9.5–10 years 2.771 2.997 3.328 3.706 4.180 4.714 5.025 5.597 5.835
10–10.5 years 2.789 3.015 3.346 3.724 4.196 4.727 5.038 5.605 5.840
10.5–10.9 years 2.810 3.033 3.367 3.743 4.211 4.740 5.048 5.613 5.846
TC/HDL-C
2–2.5 years 2.08 2.31 2.67 3.09 3.70 4.53 5.12 6.56 7.36
2.5–3 years 2.04 2.27 2.61 3.02 3.61 4.40 4.98 6.35 7.11
3–3.5 years 2.00 2.22 2.55 2.95 3.52 4.28 4.83 6.14 6.86
3.5–4 years 1.96 2.17 2.49 2.88 3.42 4.16 4.69 5.93 6.62
4–4.5 years 1.92 2.12 2.43 2.81 3.33 4.04 4.54 5.74 6.38
4.5–5 years 1.88 2.08 2.38 2.74 3.25 3.93 4.41 5.55 6.16
5–5.5 years 1.84 2.04 2.33 2.68 3.17 3.83 4.29 5.38 5.97
5.5–6 years 1.81 2.01 2.29 2.64 3.11 3.74 4.19 5.24 5.80
6–6.5 years 1.79 1.98 2.26 2.60 3.06 3.67 4.11 5.11 5.65
6.5–7 years 1.78 1.96 2.24 2.56 3.01 3.61 4.03 5.01 5.52
7–7.5 years 1.76 1.94 2.21 2.53 2.97 3.56 3.97 4.91 5.41
7.5–8 years 1.75 1.93 2.20 2.52 2.95 3.52 3.92 4.83 5.31
8–8.5 years 1.76 1.93 2.20 2.51 2.93 3.49 3.88 4.78 5.25
8.5–9 years 1.76 1.94 2.20 2.51 2.93 3.48 3.86 4.74 5.20
9–9.5 years 1.77 1.94 2.20 2.51 2.92 3.47 3.84 4.70 5.15
9.5–10 years 1.77 1.94 2.20 2.50 2.91 3.45 3.82 4.65 5.09
10–10.5 years 1.77 1.94 2.20 2.50 2.90 3.43 3.79 4.61 5.03
10.5–10.9 years 1.77 1.94 2.20 2.49 2.89 3.41 3.77 4.57 4.98
Triglycerides (mmol l− 1)
2–10.9 years 0.509 0.509 0.509 0.509 0.542 0.757 1.028 1.526 2.044
Abbreviations: HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TC, total cholesterol.
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interpretational level, it allows for visualising nonlinear changes,
for example, age-related changes in the parameter of interest (in
casu blood lipids). In addition, these nonlinear changes can also be
established for non-normal variables, as it is based on nonpara-
metric modelling. To the authors’ knowledge, no previous study
has ever established reference values for blood lipids from such a
large sample of healthy children from populations within such a
wide geographical scope in Europe.
However, although the large numbers and the geographical
distribution are clearly important positive points for establishing a
set of reference values that could be framed as ‘European’, there
are some limitations to be considered as well. As already pointed
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Figure 2. Age-speciﬁc reference curves for blood cholesterol (TC, HDL-C, LDL-C and TC/HDL-C) in boys and girls.
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out in the editorial, the regions included in every IDEFICS
(Identiﬁcation and prevention of Dietary- and lifestyle induced
health Effects in Children and InfantS) country were not per se
representative for the whole country and this was fully compatible
with the original research questions addressed by this European
Union-funded project. Nevertheless, there are no obvious reasons
in any of the participating countries to assume that regional
differences in lifestyle in the selected areas would have been
operational at a level that could differentially inﬂuence blood lipid
values on population level. Both the control and intervention
regions in all countries were chosen to be comparable to each
other and to the national average as far as classical socioeconomic
and demographic indicators are concerned. In addition, a most
meticulous standardisation of measurements and analytical
circumstances and subsequent procedures for quality control
have been successfully implemented in the context of this
collaborative endeavour. As a result, we do not present reference
values stratiﬁed by country.
In the authors’ view, the set of values in this paper can be used
as an interpretational framework in clinical and public health
practice with a fairly high conﬁdence towards true representation
of European biological variability in the different lipid fractions
and their evolution as a function of age during early childhood. A
major limitation for generalised use in medical practice is the age
group, as reference values during pubertal maturation might be
even more relevant for universal screenings.
Obese children—as deﬁned by the International Obesity Task
Force criteria19—have been omitted from the database used for
the analyses in this paper. The reason for this is that excessive fat
deposition is documented as positively correlated with blood lipid
levels, also in children and adolescents.30,31 As reference values
are expected to reﬂect as much as possible the biological variation
in a disease-free population, it was a logical methodological
consideration to withdraw obese children from the results, even if
sensitivity analyses showed that their inclusion did not signiﬁ-
cantly change the overall conclusions or reference standards
(Supplementary Figure A).
Obviously, there are other factors than disease (for example,
lifestyle factors) that can inﬂuence blood lipids at the individual
level and that can also affect population distributions. However,
such inﬂuences cannot reasonably be ﬁltered out of the study
population in a systematic way as there is no evidence-based
framework for understanding at individual level which dose of
lifestyles or personal traits would have to be considered as
critically inﬂuencing blood lipids at this age and would therefore
qualify as exclusion criterion. The well-documented problem of
familial dyslipidaemias has been left outside the scope of
exclusions as well. Although it is appreciated that a relevant
proportion of children with familial dyslipidaemia will already
present with substantial elevation of LDL-C levels, there is no
information available that would allow accurate identiﬁcation (and
subsequent exclusion) of these children.1
It has to be noted that the results for blood lipids are partly
based on venous blood analyses and partly based on capillary
blood analyses—in both cases however the Cholestech protocol
and equipment was used. The analysis of both blood fractions was
done immediately after blood withdrawal on the whole-blood
fraction. Studies on the inﬂuence of the puncture site on the blood
lipid levels are scarce but it has been shown that cholesterol
measurement in ﬁngertip capillary specimens is in close agree-
ment (within 1.7%) with conventional venous measurement.32 In
contrast, however, in our study sample, we found signiﬁcantly
higher levels of TC, HDL-C and LDL-C and signiﬁcantly lower levels
of TG in the venous samples. The mean differences ranged
between 0.02mmol l− 1 for HDL-C and 0.07mmol l− 1 for TG. Taken
into account that, according to the meta-analysis of Gordon
et al.,33 a 0.026 mmol l− 1 increase in HDL-C was associated with a
signiﬁcant coronary heart disease risk decrement of 2% in men
and 3% in women, these differences might be relevant from a
public health point of view. Nevertheless, compared with the
broad range of lipid levels between the 5th and the 95th percentile
in our age group, it was decided to calculate the reference values
on the pooled data. Moreover, sensitivity analyses revealed no
large differences in reference curves/values when including the
capillary blood samples (Supplementary Figure B).
Geographical and historical comparisons of data sets can be
interesting, although they have to be treated with caution in view
of potential differences in recruitment, ﬁeld work conditions and
analytical techniques. Also, time trends could exist, for example, a
favourable overall trend in serum lipid concentrations was
observed among youths in the United States between 1988–1994
and 2007–2010, in contrast, almost 1 in 10 had elevated TC in
2007–2010.34
A large sample of French children at the age of 4 years has been
studied on TC levels by Vincelet et al.35 in 2002. Mean values for
TC were at 4.5 mmol l− 1 in girls and 4.4 mmol l− 1 in boys, which is
substantially higher than the values found in our European
sample.
In contrast with these French ﬁndings, an Italian study36 in more
than 7000 Italian children from the Lazio region showed a mean
TC of 3.5 mmol l− 1 in boys and 3.7 mmol l− 1 in girls, which is
clearly lower than the values in our European children. Although
differences in methodology can explain part of these differences,
these comparisons show that regional variations in lipid levels are
observed within the European region, which are likely to be
explained by differences in lifestyle factors, for example,
adherence to Mediterranean diet.
In a large sample of Chinese children from Beijing examined
in 2006,37 TC mean values were observed between 3.6 and
4.2 mmol l− 1 in boys aged 3–9 years and between 3.5 and
4.1 mmol l− 1 in girls of this age. For HDL-C, the values were
respectively between 1.1 and 1.6 mmol l− 1 and between 1.2 and
1.5 mmol l− 1. LDL-C ranged between 1.9 and 2.4 mmol l− 1 and
between 2 and 2.3 mmol l− 1. These values are also largely in line
with the European observations from our sample. The major
difference is that, in our study population, apparently, the sex
differences in HDL-C are clearly more marked with higher values
on average in boys. Related to this, the sex differences with higher
TG values in girls in our study might have clinical relevance, as TG
appear to be the main lipid risk factor in women.38,39
In a recent study carried out in Turkey,40 fasting serum lipid
values have been reported for disease-free population-based
samples of 383 boys and 248 girls in the age group 1–6 years and
522 boys and 521 girls in the age range 7–10 years. Mean values
for TC, LDL-C and HDL-C were very similar to the values found in
our sample. Remarkably, however, the serum TG values were on
average almost double the values found in the IDEFICS cohort
(respectively, 1.08, 1.05, 0.96 and 1.08 mmol l− 1).
Finally, in boys and girls from the National Health and Nutrition
Examination survey carried out between 1988 and 1994 in USA,41
comparable blood lipid values were observed as in the IDEFICS
cohort, with National Health and Nutrition Examination survey TC
levels varying between 3.3 mmol l− 1 in boys aged 7–10 years and
4.3 mmol l− 1 in girls aged 7–10 years; for HDL-C, the National
Health and Nutrition Examination survey values ranged from 1.3
mmol l− 1 in girls aged 3–6 years to 1.4 mmol l− 1 in boys aged
7–10 years.
It is worthwhile comparing the data from this cohort of
European children with those from another European cohort of
adolescents (HELENA42) studied in 2006—hence comparing two
European birth cohorts with a time interval of on average around
6 years.
In HELENA, serum lipid values of 1049 European adolescents
(12.5–17.5 years) were measured and showed sex differences with
consistently higher lipid values (HDL-C, LDL-C, TC and TG) in girls
as compared with boys. The same applies to the IDEFICS cohort,
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except that HDL-C levels were higher in boys. This ﬁnding
conﬁrms once more that pubertal changes in boys interact with
HDL metabolism and are at the origin of the well-known sex
divergence in HDL metabolism in adults.
CONCLUSION
In the authors’ view, these new and recent references may serve
as a European orientation of blood lipid values in children in the
context of standard medical practice and for the purpose of public
health screening.
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